The Elizabeth Glaser Pediatric AIDS Foundation that begun as three mothers around a kitchen table is now the leading global nonprofit dedicated to eliminating pediatric HIV and AIDS. Three mothers united to end AIDS in children as a result The Pediatric AIDS Foundation (PAF) was launched by Elizabeth Glaser, Susie Zeegen, and Susan DeLaurentis to raise money for pediatric AIDS research. PAF made its first research grant, $60,000, to Dr. Richard Stiehm of UCLA. Over the next 30 years, PAF/EGPAF awarded at total of 1,100 research grants, representing $78 million in combined funding.
Elizabeth Glaser died of AIDS-related causes on Dec. 3, and the Pediatric AIDS Foundation then was renamed as Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) in her memory. Nevirapine reduced mother-to-child transmission of HIV by 50 percent with single doses given to the mother during labor and to the infant following birth in the landmark HPTN 012 study, led by Laura Guay, M.D., a researcher with Johns Hopkins University.
The Elizabeth Glaser Pediatric AIDS Foundation seeks to end global pediatric HIV/AIDS through prevention and treatment programs, research, and advocacy. Our goals are
- Expand high quality, evidence-based, locally sustained HIV/AIDS programs and services, as well as strengthened health systems to end HIV/AIDS among children, adolescents, and families
- Advance research and innovation to prevent, treat, and end HIV/AIDS among children, adolescents, and families
- Advocate for global, regional, national, and local policies and guidelines, resources, and political leadership to end HIV/AIDS among children, adolescents, and families